Search Results - "Cogburn, J. N."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats by PAULSON, S. K, ZHANG, J. Y, MAZIASZ, T. J, SCHOENHARD, G. L, BURTON, E. G, BREAU, A. P, HRIBAR, J. D, LIU, N. W. K, JESSEN, S. M, LAWAL, Y. M, COGBURN, J. N, GRESK, C. J, MARKOS, C. S

    Published in Drug metabolism and disposition (01-05-2000)
    “…The pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1 H -pyrazol-1-yl]…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Sulphation of proteochondroitin and 4-methylumbelliferyl β-D-xyloside-chondroitin formed by mouse mastocytoma cells cultured in sulphate-deficient medium by SILBERT, J. E, GEETHA SUGUMARAN, COGBURN, J. N

    Published in Biochemical journal (15-11-1993)
    “…Mouse mastocytoma cells were cultured in medium containing [3H]GlcN and concentrations of [35S]sulphate varying from 0.01 to 0.5 mM. Intracellular…”
    Get full text
    Journal Article
  6. 6

    Simultaneous sulfation of endogenous chondroitin sulfate and chondroitin-derived oligosaccharides. Studies with separate 4-sulfating and 6-sulfating microsomal systems by Sugumaran, G, Cogburn, J N, Silbert, J E

    Published in The Journal of biological chemistry (25-09-1986)
    “…Microsomal preparations from chondroitin 6-sulfate-producing chick embryo epiphyseal cartilage and from chondroitin 4-sulfate-producing mouse mastocytoma cells…”
    Get full text
    Journal Article
  7. 7

    The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation by Cogburn, J N, Silbert, J E

    Published in Carbohydrate research (15-08-1986)
    “…Previous work has shown that odd-numbered oligosaccharides containing nonreducing terminal, non-sulfated N-acetylgalactosamine (GalNAc) or 6-sulfated GalNAc…”
    Get more information
    Journal Article
  8. 8

    A model of human small intestinal absorptive cells. 1. Transport barrier by Cogburn, J N, Donovan, M G, Schasteen, C S

    Published in Pharmaceutical research (01-02-1991)
    “…The Caco-2 cell culture model of human small intestinal absorptive cells was used to investigate transepithelial transport. Transport of permeability markers…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Increased proteoglycan synthesis following the differentiation of F9 embryonal carcinoma cells: formation of a differentiation-specific proteoheparan sulfate by Baldwin, C T, Silbert, J E, Humphries, D E, Cogburn, J N, Smith, B D

    Published in Matrix (Stuttgart) (01-11-1989)
    “…We have examined changes in proteoglycan synthesis by F9 embryonal carcinoma cells after the cells have been treated with retinoic acid or retinoic acid plus…”
    Get more information
    Journal Article
  12. 12
  13. 13

    1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents by Li, J J, Anderson, G D, Burton, E G, Cogburn, J N, Collins, J T, Garland, D J, Gregory, S A, Huang, H C, Isakson, P C, Koboldt, C M

    Published in Journal of medicinal chemistry (27-10-1995)
    “…A series of 1,2-diarylcyclopentene methyl sulfones and sulfonamides have been shown to be remarkably potent and selective cyclooxygenase-2 (COX-2) inhibitors…”
    Get full text
    Journal Article
  14. 14

    Physiological and cytotoxic effects of Ca(2+) ionophores on Caco-2 paracellular permeability: relationship of 45Ca(2+) efflux to 51 Cr release by Rutten, M J, Cogburn, J N, Schasteen, C S, Solomon, T

    Published in Pharmacology (1991)
    “…The human intestinal cell line, Caco-2, and the Ca2+ ionophores, A23187 and ionomycin, were used to determine the interrelationships of 45Ca(2+) efflux,…”
    Get more information
    Journal Article
  15. 15